Zhu‐Xu Zhang

1.9k total citations
47 papers, 1.5k citations indexed

About

Zhu‐Xu Zhang is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Zhu‐Xu Zhang has authored 47 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 19 papers in Immunology and 11 papers in Surgery. Recurrent topics in Zhu‐Xu Zhang's work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (11 papers) and Cell death mechanisms and regulation (10 papers). Zhu‐Xu Zhang is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (11 papers) and Cell death mechanisms and regulation (10 papers). Zhu‐Xu Zhang collaborates with scholars based in Canada, China and United States. Zhu‐Xu Zhang's co-authors include Anthony M. Jevnikar, Wei‐Ping Min, Bertha García, Xuyan Huang, Aaron Haig, Dameng Lian, Li Zhang, Hongtao Sun, Xiufen Zheng and Xusheng Zhang and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Zhu‐Xu Zhang

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhu‐Xu Zhang Canada 23 731 545 214 194 176 47 1.5k
Peixiang Lan China 17 586 0.8× 489 0.9× 146 0.7× 165 0.9× 231 1.3× 34 1.2k
Simi Ali United Kingdom 30 828 1.1× 707 1.3× 491 2.3× 200 1.0× 144 0.8× 105 2.4k
Tomomi Toubai Japan 29 1.4k 1.9× 780 1.4× 156 0.7× 207 1.1× 293 1.7× 101 2.7k
Fumihiko Kimura Japan 21 781 1.1× 700 1.3× 270 1.3× 157 0.8× 208 1.2× 138 2.1k
Scott Adler United States 19 331 0.5× 495 0.9× 517 2.4× 119 0.6× 87 0.5× 39 1.9k
Sylvain Perruche France 23 1.4k 1.9× 444 0.8× 149 0.7× 103 0.5× 94 0.5× 55 1.9k
Xuyan Huang Canada 16 798 1.1× 331 0.6× 176 0.8× 45 0.2× 76 0.4× 30 1.2k
René Geyeregger Austria 21 508 0.7× 457 0.8× 235 1.1× 122 0.6× 348 2.0× 39 1.5k
Ramanjaneyulu Allam Switzerland 25 1.6k 2.2× 1.3k 2.4× 186 0.9× 139 0.7× 228 1.3× 42 2.7k
Damián Maseda United States 18 652 0.9× 353 0.6× 107 0.5× 38 0.2× 96 0.5× 23 1.3k

Countries citing papers authored by Zhu‐Xu Zhang

Since Specialization
Citations

This map shows the geographic impact of Zhu‐Xu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhu‐Xu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhu‐Xu Zhang more than expected).

Fields of papers citing papers by Zhu‐Xu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhu‐Xu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhu‐Xu Zhang. The network helps show where Zhu‐Xu Zhang may publish in the future.

Co-authorship network of co-authors of Zhu‐Xu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhu‐Xu Zhang. A scholar is included among the top collaborators of Zhu‐Xu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhu‐Xu Zhang. Zhu‐Xu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ni, Rui, Xiaoyun Ji, Ting Cao, et al.. (2024). Nicotinamide mononucleotide protects septic hearts in mice via preventing cyclophilin F modification and lysosomal dysfunction. Acta Pharmacologica Sinica. 46(4). 976–988. 7 indexed citations
2.
Ni, Ruiqing, Ting Cao, Xiaoyun Ji, et al.. (2024). DNA damage-inducible transcript 3 positively regulates RIPK1-mediated necroptosis. Cell Death and Differentiation. 32(2). 306–319. 3 indexed citations
3.
Lü, Haitao, Jifu Jiang, Xuyan Huang, et al.. (2024). The CaMK Family Differentially Promotes Necroptosis and Mouse Cardiac Graft Injury and Rejection. International Journal of Molecular Sciences. 25(8). 4428–4428.
4.
Cao, Ting, Rui Ni, Weimin Ding, et al.. (2022). MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes. Cardiovascular Diabetology. 21(1). 165–165. 31 indexed citations
5.
Zhao, Jiangqi, Xuyan Huang, Jifu Jiang, et al.. (2021). Toll-like receptor 3 is an endogenous sensor of cell death and a potential target for induction of long-term cardiac transplant survival. American Journal of Transplantation. 21(10). 3268–3279. 10 indexed citations
6.
Cao, Ting, Shuai Fan, Dong Zheng, et al.. (2019). Increased calpain-1 in mitochondria induces dilated heart failure in mice: role of mitochondrial superoxide anion. Basic Research in Cardiology. 114(3). 17–17. 57 indexed citations
7.
8.
Wang, Hongmei, Xusheng Zhang, Xiufen Zheng, et al.. (2016). Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways. Scientific Reports. 6(1). 33869–33869. 11 indexed citations
9.
Yang, Yunbo, Zhu‐Xu Zhang, Dameng Lian, et al.. (2014). IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury. Kidney International. 87(2). 396–408. 91 indexed citations
10.
Lau, Arthur, Karim Khan, Ziqin Yin, et al.. (2014). Serine Protease Inhibitor-6 Inhibits Granzyme B–Mediated Injury of Renal Tubular Cells and Promotes Renal Allograft Survival. Transplantation. 98(4). 402–410. 14 indexed citations
11.
Suzuki, Motohiko, Xiufen Zheng, Xusheng Zhang, et al.. (2010). A novel allergen-specific therapy for allergy using CD40-silenced dendritic cells. Journal of Allergy and Clinical Immunology. 125(3). 737–743.e6. 25 indexed citations
12.
Feng, Biao, Gang Chen, Xiufen Zheng, et al.. (2009). Small Interfering RNA Targeting RelB Protects Against Renal Ischemia-reperfusion Injury. Transplantation. 87(9). 1283–1289. 39 indexed citations
13.
Zhang, Zhu‐Xu, Shuang Wang, Xuyan Huang, et al.. (2008). NK Cells Induce Apoptosis in Tubular Epithelial Cells and Contribute to Renal Ischemia-Reperfusion Injury. The Journal of Immunology. 181(11). 7489–7498. 128 indexed citations
14.
Zhang, Xusheng, Mu Li, Dameng Lian, et al.. (2008). Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection. Clinical Immunology. 127(3). 313–321. 40 indexed citations
15.
Wang, Shuang, et al.. (2007). Donor double‐negative Treg promote allogeneic mixed chimerism and tolerance. European Journal of Immunology. 37(12). 3455–3466. 26 indexed citations
16.
Zhang, Zhu‐Xu, Hao Wang, Jacqueline Arp, et al.. (2006). Double-Negative T Cells, Activated by Xenoantigen, Lyse Autologous B and T Cells Using a Perforin/Granzyme-Dependent, Fas-Fas Ligand-Independent Pathway. The Journal of Immunology. 177(10). 6920–6929. 65 indexed citations
17.
Zhang, Zhu‐Xu, William L. Stanford, & Li Zhang. (2002). Ly-6A is critical for the function of double negative regulatory T cells. European Journal of Immunology. 32(6). 1584–1584. 41 indexed citations
18.
Zhang, Zhu‐Xu, David R. Milich, Darrell L. Peterson, et al.. (1997). Interferon‐α Treatment Induces Delayed CD4 Proliferative Responses to the Hepatitis C Virus Nonstructural Protein 3 Regardless of the Outcome of Therapy. The Journal of Infectious Diseases. 175(6). 1294–1301. 39 indexed citations
19.
20.
Zhang, Zhu‐Xu, Zhibing Yun, Margaret Chen, Anders Sönnerborg, & Matti Sällberg. (1995). Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: Relation to genomic typing by the polymerase chain reaction. Journal of Medical Virology. 45(1). 50–55. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peixiang Lan Breakdown of academic impact, for papers by Simi Ali Breakdown of academic impact, for papers by Tomomi Toubai Breakdown of academic impact, for papers by Fumihiko Kimura Breakdown of academic impact, for papers by Scott Adler Breakdown of academic impact, for papers by Sylvain Perruche Breakdown of academic impact, for papers by Xuyan Huang Breakdown of academic impact, for papers by René Geyeregger Breakdown of academic impact, for papers by Ramanjaneyulu Allam Breakdown of academic impact, for papers by Damián Maseda
Rankless by CCL
2026